No Data
Zhongtai: Innovative Drugs lead the market, pay attention to Q1 performance + policy catalysis.
In April, the pharmaceutical Sector is expected to continue its structural market trend, with Innovative Drugs as the main line and thematic opportunities rotating.
FOSUN PHARMA (02196): FOSUN Technology handles the release of 27 million shares of A-shares.
FOSUN PHARMA (02196) announced that the company received a notice from its controlling Shareholder, Shanghai FOSUN Hi-Tech, on April 2, 2025...
FOSUN PHARMA (600196.SH): A total of 1.6133 million A-shares have been repurchased.
On April 2, Gelonghui announced that FOSUN PHARMA (600196.SH) implemented its A-share repurchase plan for the first time on March 26, 2025; as of March 31, 2025, a total of 1.6133 million A-shares have been repurchased (approximately 0.0604% of the company's total shares as of March 31, 2025), with a total repurchase amount of approximately 39.9941 million yuan (excluding trading costs), a maximum price of 25.39 yuan/share, and a minimum price of 24.54 yuan/share. The company initially implemented the H-share buyback plan on January 23, 2025; as of 2025.
The Medical Industry is frequently benefiting from favorable policies, and FOSUN PHARMA (600196.SH; 02196) is focusing on several achievements of Innovative Drugs and medical devices that have been implemented Globally.
The optimization of procurement policies has provided a more relaxed market environment for Innovative Drugs companies, and FOSUN PHARMA, as a leading enterprise in innovation, undoubtedly benefits from this.
The entire pharmaceutical sector has surged sharply; what happened?
On Monday, all AH Stocks in the pharmaceutical Sector surged, with innovative drugs performing the strongest. The Yinhua CSI Innovative Drugs Industry ETF collectively rose sharply, driven by three main factors: the relaxation of collective procurement, overseas license authorizations, and improvement in Earnings Reports that will reshape the Industry landscape.
Introducing two major international capitals, Fosun UnitedHealth is starting a new round of capital increase and share expansion, and after multiple rounds of financing, it will focus on the Fosun ecosystem.
① Planning to introduce two major international capitals: the International Finance Corporation and the Asian Development Bank; ② The total cash investment from investors amounts to 0.81 billion yuan (or the equivalent in USD); ③ Since its establishment, multiple rounds of funding have been obtained through shareholder donations and capital increases.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}